Cardiomyopathy Associated with Anti-SARS-CoV-2 Vaccination: What Do We Know?

The SARS-CoV-2 pandemic has mobilized many efforts worldwide to curb its impact on morbidity and mortality. Vaccination of the general population has resulted in the administration of more than 6,700,000,000 doses by the end of October 2021, which is the most effective method to prevent hospitalizat...

Descripción completa

Detalles Bibliográficos
Autores principales: Parra-Lucares, Alfredo, Toro, Luis, Weitz-Muñoz, Sebastián, Ramos, Cristóbal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708989/
https://www.ncbi.nlm.nih.gov/pubmed/34960761
http://dx.doi.org/10.3390/v13122493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708989/
https://www.ncbi.nlm.nih.gov/pubmed/34960761
http://dx.doi.org/10.3390/v13122493

Ejemplares similares